机器学习提名了帕金森病中的内醇途径和新型基因
Eric Yu1,2, Roxanne Larivière3, Rhalena A Thomas3,4
1Department of Human Genetics, McGill University, Montreal, Quebec H3A 0G4, Canada.
Brain : a journal of neurology
|October 7, 2023
概括
研究人员使用机器学习从遗传位置识别出潜在的帕金森病基因. 这项研究强调了新的途径和特定的基因,如SPNS1和MLX,涉及帕金森病的发病因子.
科学领域:
- 遗传学 是一个遗传学.
- 神经科学是一个神经科学.
- 计算生物学 计算生物学
背景情况:
- 全基因组关联研究 (GWAS) 已经确定了78个与帕金森病 (PD) 相关的位置.
- 这些与PD相关的位点背后的特定基因和生物机制在很大程度上仍未确定.
- 了解这些遗传驱动因素对于推动PD研究和治疗开发至关重要.
研究的目的:
- 为GWAS识别的每个PD相关位点提名候选基因.
- 识别与帕金森病相关的新型遗传变异和生物途径.
- 利用机器学习从复杂的遗传数据中预测PD相关基因.
主要方法:
- 训练了一种机器学习模型,使用来自大脑组织和多巴胺基神经元的基因组,转录组和表观基因组数据.
- 综合多omics数据来预测基因与帕金森病的基因关联.
- 对罕见变异进行负荷测试,以确定相关的基因和途径.
主要成果:
- 针对78个帕金森病位点中的每一个,提名了顶级候选基因.
- 确定了因诺酸盐生物合成途径 (包括INPP5F,IP6K2,ITPKB,PPIP5K2) 作为一种可能参与PD的新途径.
- 发现了SPNS1和MLX中常见的编码变异的证据,以及CNIP3,LSM7,NUCKS1中的罕见变异,以及与PD相关的聚醇/异醇酸盐路径.
结论:
- 该研究成功提名了候选基因,并确定了帕金森病的新途径.
- 特定的基因 (SPNS1,MLX,CNIP3,LSM7,NUCKS1) 和内醇酸盐通路需要进一步研究它们在PD中的作用.
- 功能性研究对于验证这些已识别的基因和途径在帕金森病病原发生过程中的参与至关重要.
更多相关视频
09:21Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
Published on: July 7, 2023
1.5K
14:45Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
Published on: July 29, 2022
6.0K
相关概念视频
Parkinson's Disease: Overview
587
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
587
Parkinson's Disease: Treatment
287
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
287
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
